Argenx Se Revenue per Employee (ARGX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Argenx Se  (NASDAQ: ARGX)
 

Argenx Se's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 89.08% in the fourth quarter 2025, year on year to cumulative value of $8,399 million, Argenx Se's revenue per employee grew on a trailing twelve months basis to $ 7,316,521, this marks a new company high.
Within the Healthcare sector Employees of 4 other companies have achieved higher revenue per employee. While Argenx Se's total ranking has deteriorated compared to the previous quarter from 0 to 117. Argenx Se has 1,148 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ARGX Revenue per Employee (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Revenue Change 89.08 % - - - 78.05 %
Sales per Employee (TTM) $ 7,316,521 3,869,573 3,869,573 3,869,573 3,869,573
ARGX's Total Ranking # 117 # 0 # # #
Seq. Revenue Change - - - - -

ARGX Company Profile >> Back to ARGX Efficiency Comparisons >> Compare ARGX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 2
Healthcare Sector # 5
Overall Market # 117

Revenue per Employee Statistics
High Average Low
$ 7,316,521 $ 3,526,254 $ 745,656
(Dec 31 2025)   (Dec 31 2022)



Financial Statements
Argenx Se's Revenue MRQ $ 8,399 Millions Visit ARGX's Income Statement
Argenx Se's Revenues TTM $ 8,399 Millions Visit ARGX's aggregate revenue growth
What are ARGX's Sales? Visit ARGX's Sales by Segment




Other Ratios
Argenx Se's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ARGX's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ARGX's Competitors
Revenue per Employee for ARGX's Suppliers
Revenue per Employee for ARGX's Customers

You may also want to know
ARGX's Sales Growth Rates ARGX's Pe Price to earnings ratio ARGX's Receivables Turnover Ratio ARGX's Stock Quote
ARGX's Net Income Growth Rates ARGX's Ps Price to Sales ratio ARGX's Sales per Employee ARGX's Asset Turnover Ratio
ARGX's Net Margin ARGX's Pb Price to Book ratio ARGX's Financial Strength Ratios ARGX's Dividend Payout Ratio
Date modified: 2026-07-07T09:15:04+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
Atara Biotherapeutics Inc   8,668,214.29 $ 121.355  Million 14 
Ascendis Pharma A  8,065,478.40 $ 806.548  Million 100 
Inmode Ltd   7,561,122.45 $ 370.495  Million 49 
Argenx Se  7,316,520.91 $ 8,399.366  Million 1,148 
Agilon Health Inc   6,930,579.44 $ 5,932.576  Million 856 
Ligand Pharmaceuticals Incorporated  5,703,978.72 $ 268.087  Million 47 
Anika Therapeutics Inc   5,371,761.90 $ 112.807  Million 21 
P3 Health Partners Inc   4,559,625.00 $ 1,459.080  Million 320 
Xeris Biopharma Holdings Inc   4,489,923.08 $ 291.845  Million 65 
Novo Nordisk A  4,446,644.13 $ 309,064.000  Million 69,505 
Community Health Systems Inc   4,027,419.35 $ 12,485.000  Million 3,100 
Xoma Royalty Corporation  3,724,928.57 $ 52.149  Million 14 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.